The influence of venetoclax, used alone or in combination with cladribine (2-CdA), on CLL cells apoptosis in vitro: Preliminary results.

MLA

Kubiak, Aleksandra Beata, et al. “The Influence of Venetoclax, Used Alone or in Combination with Cladribine (2-CdA), on CLL Cells Apoptosis in Vitro: Preliminary Results.” Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University, vol. 31, no. 9, Sept. 2022, pp. 1023–33. EBSCOhost, https://doi.org/10.17219/acem/148142.

APA

Kubiak, A. B., Ziółkowska, E. I., Korycka-Wołowiec, A. B., Robak, T., & Wołowiec, D. (2022). The influence of venetoclax, used alone or in combination with cladribine (2-CdA), on CLL cells apoptosis in vitro: Preliminary results. Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University, 31(9), 1023–1033. https://doi.org/10.17219/acem/148142

Chicago

Kubiak, Aleksandra Beata, Ewelina Izabela Ziółkowska, Anna Barbara Korycka-Wołowiec, Tadeusz Robak, and Dariusz Wołowiec. 2022. “The Influence of Venetoclax, Used Alone or in Combination with Cladribine (2-CdA), on CLL Cells Apoptosis in Vitro: Preliminary Results.” Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University 31 (9): 1023–33. doi:10.17219/acem/148142.